SCHEMBL22633971

SCHEMBL22633971

FC(F)(F)c1ccc(-c2ccccc2Oc2ccccc2-c2ccc(C(F)(F)F)cc2)cc1.c1ccc(Pc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.47
▸ BACE1 P56817 2/20 0.43
▸ AR P10275 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ FFAR1 O14842 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ CASR P41180 2/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ PTGDR2 Q9Y5Y4 2/20 0.37
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ RXRG P48443 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22634024 0.83 NCOA1 (0.42) ALDH1A1CYP11B1CYP11B2FFAR1FFAR4
SCHEMBL22634082 0.82 FFAR4 (0.46) ARFFAR1FFAR4NCOA1NCOA3
SCHEMBL22634001 0.80 KIF11 (0.39) KIF11BACE1ARCYP11B1CYP11B2
SCHEMBL28672016 0.79 NCOA1 (0.62) KIF11BACE1ARALDH1A1TSHR
SCHEMBL27948037 0.77 ALDH1A1 (0.59) KIF11BACE1ALDH1A1TSHRCYP19A1
SCHEMBL25429460 0.77 KIF11 (0.53) KIF11BACE1ARALDH1A1FFAR1
SCHEMBL5295496 0.75 TRPV1 (0.55) KIF11BACE1ARTSHRCASR
SCHEMBL29786814 0.75 TRPV1 (0.55) KIF11BACE1ARTSHRCASR
SCHEMBL11310344 0.73 KIF11 (0.77) KIF11BACE1ALDH1A1TSHRPTGDR2
SCHEMBL2367672 0.73 BACE1 (0.58) KIF11BACE1ALDH1A1FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988494-B2 Europium complex TOSOH CORPORATION (JP) 2021-04-27 — — US disclosed
US-20200354389-A1 EUROPIUM COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988494-B2 Europium complex SSB, XPA, UACA KIF11 2421/4885BACE1 2788/4885AR 830/4885
US-20200354389-A1 EUROPIUM COMPLEX SSB, XPA, UACA KIF11 2421/4885BACE1 2788/4885AR 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback